ePatientFinder completes $8.2 million Series B round of financing: providing patients with more clinical trial opportunities

On June 9, ePatientFinder, a well-known medical technology company based in Austin, USA, announced the completion of a $8.2 million Series B round of financing led by a strategic medical technology investor consortium (unnamed). So far, the company has raised a total of 11 million US dollars.

The main task of ePatientFinder is to provide physicians with more clinical trial opportunities that can change the lives of patients. Its innovative clinical trial exchange platform brings together life sciences organizations (including many top 10 pharmaceutical companies, medical device companies and new drug contract research organizations) with a wide range of physicians who are in need of clinical trial treatments for patients ( Closely connected from clinics, large hospitals and trusted medical organizations.

For example, when a drug experiment publishes a clinical trial quota in the corresponding medical field, doctors in the field will be notified immediately; on the other hand, the platform can also use the big data calculation to identify a qualified patient for the doctor.

Providing more clinical trial opportunities for patients, the medical technology platform ePatientFinder completed $8.2 million in Series B financing

In the beginning, ePatientFinder mainly used a large number of first-level electronic medical records to coordinate information with health information technology partners. Over time, the platform intends to add other healthcare providers and EHR partners to the “Clinical Experimental Switching System” to further accelerate the growth of healthcare-related supplier networks.

The goal of the platform is to "not miss any eligible patient." After mastering millions of patient medical records and using sophisticated EHR data algorithms, ePatientFinder helps physicians identify and refer patients' clinical trial qualifications and the latest approval procedures they may not know through a three-layer screening process.

“Generally speaking, patient recruitment in clinical trials has always been a major challenge for the industry. ePatientFinder uses trustworthy doctor-patient relationships and ENR data to confirm its leadership in this problem solution. Of course, this is also "We can get the root cause of $8 million in financing," said Tom Dorsett, co-founder and CEO of ePatientFinder. "Our partners and investors are aligned with ePatientFinder's goals - technical solutions to the recruitment of clinical trials. Inefficiency issues. These funds will help us continue to expand the range of options available to patients on the ePatientFinder platform for effective treatment options."

Self-propelled Sprayer

Self-Propelled Sprayer,Self-Propelled Boom Sprayer,Self-Propelled Power Boom Sprayer,Self-Propelled Boom Sprayer With Rice

Taizhou Yingtian Agricultural Machinery Manufacturing Co., Ltd. , https://www.sakuradaagc.com